Autodesk Fell on a Four-Cent 'Miss.' Its Free Cash Flow Is the Real Story.

Autodesk beat its fiscal second quarter and the stock fell about 5% after the bell anyway. By the next session it traded right back up, roughly 6%. The reason for the round trip — full-year guidance that came in light — was a gap of four cents on the midpoint. Four cents is the wrong number for any investor to be buying or selling on. The cash flow is the number that matters here, and on this print it kept improving.

Start with what the quarter actually showed. Revenue grew 16% to $2.05 billion, 14% in constant currency, and adjusted earnings came in at $3.30 a share against $3.12 expected. Free cash flow rose 24% to $561 million. Adjusted operating margin reached 41%, up two points, and subscriptions grew 17% on renewal rates the company described as better than expected. This is not a decelerating business protecting itself with accounting. It is a franchise with gross margins north of 90% compounding at a double-digit rate.

And the "guidance miss" was not even a cut. Autodesk raised its fiscal 2027 revenue and billings targets, to $8.295 billion to $8.345 billion and $8.575 billion to $8.65 billion, with free cash flow narrowed to $2.725 billion to $2.75 billion — a range that now absorbs about $45 million of deal costs. The line everyone quoted was adjusted EPS: $12.52 to $12.60, midpoint $12.56, against a $12.60 consensus. The market sold a four-cent optical on a print that raised the two top-line numbers the company controls.

Behind that optical sit two real worries that deserve straight answers. The first is the deal. In May, Autodesk agreed to buy MaintainX, a maintenance and operations software company, for about $3.6 billion in cash, the largest acquisition in its history, at roughly 27 times MaintainX's forward annual recurring revenue of above $135 million. It closed in the quarter, and the purchase accounting is a large part of why the GAAP earnings range of $7.89 to $8.72 sits so far below the adjusted range of $12.52 to $12.60. A big chunk of what reads as "guidance dilution" is a bill Autodesk chose to pay for a new business, not a sign of decay in the old one.

The second worry is the metric that usually predicts this company's growth. Contracted-but-unbilled revenue, the "cRPO," grew 12% last quarter, down from the 18% to 20% pace of recent quarters. Billings tell the same story: up 33% in the December quarter, up just 10% now. Management's explanation is that it is deliberately unwinding multi-year prepaid deals — cutting the discounts it used to offer and pushing customers to cleaner annual renewals — which shrinks the reported backlog even as it raises the price customers actually pay. Management expects the pressure to persist for several quarters.

That is the fork this stock sits on. If the explanation holds, you are watching reported growth optics slow while realized price improves, and the cash flow proves it. If it does not hold — if renewals are quietly weakening and the deceleration is demand, not mix — then roughly 21x forward free cash flow is no bargain at all.

Here is the proof path I would anchor to. Fiscal 2027 free cash flow is guided to about $2.73 billion at the midpoint, roughly a third of an $8.3 billion revenue base. Against today's market capitalization near $57 billion, that is about 21x forward free cash flow, a yield close to 4.8%, and the same roughly 21x against guided adjusted EPS. That is a quality multiple, not a distressed one, paid for a business that converts a third of revenue to cash while margins rise. The market is still pricing the old risk profile — that the billing transition was a mirage and growth would roll over — while the operating setup is already getting cleaner.

The strongest bear argument deserves a fair hearing. Fiscal 2026 was flattered by that very transition: management itself flagged that the shift to annual billings for multi-year contracts skewed fiscal 2026 billings growth and created comparison challenges for fiscal 2027. Free cash flow jumped 53% to $2.41 billion while customers prepaid under the old deal shapes. This year's guide, up a more modest roughly 14% while absorbing deal costs, necessarily looks slower. The aggregate signal has also never turned — AInvest's consensus label is still Buy — so this is not a forgotten name being rescued from a graveyard. It is a quality compounder that got rattled on optics and still sits roughly 18% below its 52-week high. Bank of America, for one, kept its Buy rating with a $300 objective, arguing renewals support durable growth at or above the guided targets.

So the narrow question a buyer has to answer is only this: do you believe the cRPO slowdown is mix, not demand? What confirms it — fiscal 2027 free cash flow landing at or near the $2.7 billion guide, billings holding double-digit growth, and cRPO stabilizing instead of sliding again. What breaks it — weakening renewals, billings growth falling below roughly 10% for reasons that look like demand, or the cash number coming up short. I can be wrong again; the tripwire matters more than the conviction. But on this evidence the market sold four cents of optics and left the cash story intact. That is a setup worth watching closely, not a headline worth trusting.